Cited by 798Protein Kinase Regulation and GTPase SignalingProtein Tyrosine PhosphatasesMelanoma and MAPK Pathways

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects

Open access

Tuveson, David A, Shaw, Alice T, Willis, Nicholas A, Silver, Daniel P, Jackson, Erica L, Chang, Sandy, Mercer, Kim L, Grochow, Rebecca, Hock, Hanno, Crowley, Denise, Hingorani, Sunil R, Zaks, Tal, King, Catrina, Jacobetz, Michael A, Wang, Lifu, Bronson, Roderick T, Orkin, Stuart H, DePinho, Ronald A, Jacks, Tyler·2004·Cancer Cell

DOI 10.1016/s1535-6108(04)00085-6

Open this paper in CoChat — free account Open PDF

Abstract

Activating mutations in the ras oncogene are not considered sufficient to induce abnormal cellular proliferation in the absence of cooperating oncogenes. We demonstrate that the conditional expression of an endogenous K-ras(G12D) allele in murine embryonic fibroblasts causes enhanced proliferation and partial transformation in the absence of further genetic abnormalities. Interestingly, K-ras(G12D)-expressing fibroblasts demonstrate attenuation and altered regulation of canonical Ras effector signaling pathways. Widespread expression of endogenous K-ras(G12D) is not tolerated during embryonic development, and directed expression in the lung and GI tract induces preneoplastic epithelial hyperplasias. Our results suggest that endogenous oncogenic ras is sufficient to initiate transformation by stimulating proliferation, while further genetic lesions may be necessary for progression to frank malignancy.

Integrity signals

Registry

Crossref · 10.1016/s1535-6108(04)00085-6

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Self-citation
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint
Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,927
Self-citation
RAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citation
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566

Show all 49 references

Research works printed but not linked: 2

Bos, 1989, ras oncogenes in human cancer, Cancer Res., 49, 4682
Varmus, 1986, Biochemical mechanisms of oncogene activity, Cancer Surv., 5, 153

Sorted by citations

Items 201–300 of 793

Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo
Qiu, W., Sahin, F., Iacobuzio-Donahue, C. A., Garcia-Carracedo, D., Wang, W. M., Kuo, C.-Y., Chen, D., Arking, D. E., Lowy, A. M., Hruban, R. H., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.357 · Cited by 99
Direct reprogramming by oncogenic Ras and Myc
Ischenko, I., Zhi, J., Moll, U. M., Nemajerová, A., & Petrenko, O. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219592110 · Cited by 102
A recellularized human colon model identifies cancer driver genes
Chen, H. J., Wei, Z., Sun, J. M., Bhattacharya, A., Savage, D. J., Serda, R. E., Mackeyev, Y., Curley, S. A., Bu, P., Wang, L., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3586 · Cited by 99
Self-citation
Twist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras-Induced Lung Tumorigenesis
Tran, P. T., Shroff, E. H., Burns, T. F., Thiyagarajan, S., Das, S., Zabuawala, T., Chen, J., Cho, Y., Luong, R. H., Tamayo, P., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002650 · Cited by 108
Glioma Formation in Neurofibromatosis 1 Reflects Preferential Activation of K-RAS in Astrocytes
Dasgupta, B., Li, W., Perry, A., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.236.65.1 · Cited by 98
Endogenous Hyperinsulinemia Contributes to Pancreatic Cancer Development
Zhang, A. M. Y., Magrill, J., de Winter, T. J. J., Hu, X., Skovsø, S., Schaeffer, D. F., Kopp, J. L., & Johnson, J. D. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.003 · Cited by 97
Blocking of p53-Snail Binding, Promoted by Oncogenic K-Ras, Recovers p53 Expression and function
Lee, S.-H., Lee, S.-J., Jung, Y. S., Xu, Y., Kang, H. S., Ha, N., & Park, B.-J. (2009) · Neoplasia · doi:10.1593/neo.81006 · Cited by 100
K-RasG12D–induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to γ-secretase inhibitors
Kindler, T., Cornejo, M., Scholl, C., Liu, J., Leeman, D. S., Haydu, J. E., Fröhling, S., Lee, B. H., & Gilliland, D. G. (2008) · Blood · doi:10.1182/blood-2008-03-147587 · Cited by 97
Twisted epithelial–mesenchymal transition blocks senescence
Weinberg, R. A. (2008) · Nature Cell Biology · doi:10.1038/ncb0908-1021 · Cited by 97
YAP and TAZ are essential for basal and squamous cell carcinoma initiation
Debaugnies, M., Sánchez‐Danés, A., Rorive, S., Raphaël, M., Liagre, M., Parent, M.-A., Brisebarre, A., Salmon, I. J., & Blanpain, C. (2018) · EMBO Reports · doi:10.15252/embr.201845809 · Cited by 96
Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice
He, P., Yang, J. W., Yang, V. W., & Bialkowska, A. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.12.005 · Cited by 93
Androgen deprivation–induced NCoA2 promotes metastatic and castration-resistant prostate cancer
Qin, J., Lee, H.-J., Wu, S., Lin, S., Lanz, R. B., Creighton, C. J., DeMayo, F. J., Tsai, S. Y., & Tsai, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76412 · Cited by 98
Inactivating Icmt ameliorates K-RAS–induced myeloproliferative disease
Wahlstrom, A. M., Cutts, B. A., Liu, M., Lindskog, A., Karlsson, C., Sjogren, A.-K. M., Andersson, K., Young, S. G., & Bergö, M. O. (2008) · Blood · doi:10.1182/blood-2007-06-094060 · Cited by 93
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses
Nicolantonio, F. D., Arena, S., Gallicchio, M., Zecchin, D., Martini, M., Flonta, S. E., Stella, G. M., Lamba, S., Cancelliere, C., Russo, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808757105 · Cited by 92
Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation
Zhang, A. M. Y., Xia, Y. H., Lin, J. S. H., Chu, K., Wang, W. C. K., Ruiter, T. J. J., Yang, J. C. C., Chen, N., Chhuor, J., Patil, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.003 · Cited by 91
Uncoupling Cancer Mutations Reveals Critical Timing of p53 Loss in Sarcomagenesis
Young, N. P., Crowley, D. G., & Jacks, T. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4563 · Cited by 91
Self-citation
Knock-in of Mutant K- ras in Nontumorigenic Human Epithelial Cells as a New Model for Studying K- ras –Mediated Transformation
Konishi, H., Karakas, B., Abukhdeir, A. M., Lauring, J. D., Gustin, J. P., Garay, J. P., Konishi, Y., Gallmeier, E., Bachman, K. E., & Park, B. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0108 · Cited by 90
EWS/FLI-1 Induces Rapid Onset of Myeloid/Erythroid Leukemia in Mice
Torchia, E. C., Boyd, K. L., Rehg, J. E., Qu, C., & Baker, S. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00099-07 · Cited by 90
Identification of a New G-Quadruplex Motif in the KRAS Promoter and Design of Pyrene-Modified G4-Decoys with Antiproliferative Activity in Pancreatic Cancer Cells
Cogoi, S., Paramasivam, M., Filichev, V. V., Géci, I., Pedersen, E. B., & Xodo, L. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800874t · Cited by 89
KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK–ERK pathway in pancreatic cancer
Yang, K., Li, Y., Lian, G., Lin, H., Shang, C., Zeng, L., Chen, S., Li, J., Huang, C., Huang, K., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31248 · Cited by 88
Whole-Exome Sequencing Reveals Somatic Mutations in HRAS and KRAS, which Cause Nevus Sebaceus
Levinsohn, J. L., Tian, L. C., Boyden, L. M., McNiff, J. M., Narayan, D., Loring, E. C., Yun, D., Sugarman, J. L., Overton, J. D., Mane, S., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.379 · Cited by 88
RASopathies: unraveling mechanisms with animal models
Jindal, G. A., Goyal, Y., Burdine, R. D., Rauen, K. A., & Shvartsman, S. Y. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.020339 · Cited by 87
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Cheng, R., Li, F., Zhang, M., Xia, X., Wu, J., Gao, X., Zhou, H., Zhang, Z., Huang, N., Yang, X., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00726-7 · Cited by 87
Protein Kinase Cζ Represses the Interleukin-6 Promoter and Impairs Tumorigenesis In Vivo
Galvez, A. S., Durán, Á., Linares, J. F., Pathrose, P., Castilla, E. A., Abu‐Baker, S., Leitges, M., Díaz-Meco, M. T., & Moscat, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01294-08 · Cited by 89
Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer
Itatani, Y., Yamamoto, T. S., Zhong, C., Molinolo, A., Ruppel, J., Hegde, P. S., Taketo, M. M., & Ferrara, N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008112117 · Cited by 90
Prognostic significance of alterations in KRAS isoforms KRAS‐4A/4B and KRAS mutations in colorectal carcinoma
Abubaker, J. A., Bavi, P. P., Al‐Haqawi, W., Sultana, M., Al-harbi, S., Al-Sanea, N. A., Abduljabbar, A. S., Ashari, L. H. S., Alhomoud, S. J., Al‐Dayel, F., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2625 · Cited by 86
Ductal Pancreatic Cancer in Humans and MicePreprint
Tuveson, D. A., & Hingorani, S. R. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.040 · Cited by 86
Self-citation
RAS variant signalling
Mo, S. P., Coulson, J. M., & Prior, I. A. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180173 · Cited by 85
Therapeutic Effects of an Anti-Myc Drug on Mouse Pancreatic Cancer
Stellas, D., Szabolcs, M. J., Koul, S., Li, Z., Polyzos, A., Anagnostopoulos, C., Cournia, Z., Tamvakopoulos, C., Klinakis, A., & Efstratiadis, A. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju320 · Cited by 87
Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR
Gabitova, L., Restifo, D., Gorin, A. A., Manocha, K., Handorf, E. A., Yang, D., Cai, K. Q., Klein–Szanto, A. J., Cunningham, D., Kratz, L. E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.023 · Cited by 82
Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis
To, M. D., Rosario, R. D., Westcott, P. M. K., Banta, K. L., & Balmain, A. (2012) · Oncogene · doi:10.1038/onc.2012.404 · Cited by 82
Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex
Moscat, J., Díaz-Meco, M. T., & Wooten, M. W. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.119 · Cited by 86
Skin squamous cell carcinoma propagating cells increase with tumour progression and invasiveness
Lapouge, G., Beck, B., Nassar, D., Dubois, C., Dekoninck, S., & Blanpain, C. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.312 · Cited by 81
Short-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
Loss of Pten and activation of kras synergistically induce formation of intraductal papillary mucinous neoplasia from pancreatic ductal cells in mice
Kopp, J. L., Dubois, C. L., Schaeffer, D. F., Samani, A., Taghizadeh, F., Cowan, R. W., Rhim, A. D., Stiles, B. L., Valasek, M., & Sander, M. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.12.007 · Cited by 80
O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis
Taparra, K., Wang, H., Malek, R., Lafargue, A., Barbhuiya, M. A., Wang, X., Simons, B. W., Ballew, M., Nugent, K., Groves, J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94844 · Cited by 80
Cell Type–Specific Targeted Mutations of Kras and Pten Document Proliferation Arrest in Granulosa Cells versus Oncogenic Insult to Ovarian Surface Epithelial Cells
Fan, H., Liu, Z., Paquet, M., Wang, J., Lydon, J. P., DeMayo, F. J., & Richards, J. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3363 · Cited by 80
A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion
Ikenoue, T., Terakado, Y., Nakagawa, H., Hikiba, Y., Fujii, T., Matsubara, D., Noguchi, R., Zhu, C., Yamamoto, K., Kudo, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep23899 · Cited by 81
Genetic Deletion of RALA and RALB Small GTPases Reveals Redundant Functions in Development and Tumorigenesis
Peschard, P., McCarthy, A., Leblanc-Dominguez, V., Yeo, M., Guichard, S., Stamp, G., & Marshall, C. J. (2012) · Current Biology · doi:10.1016/j.cub.2012.09.013 · Cited by 82
Par‐4 inhibits Akt and suppresses Ras‐induced lung tumorigenesis
Joshi, J. P., Fernández-Marcos, P. J., Galvez, A. S., Amanchy, R., Linares, J. F., Durán, Á., Pathrose, P., Leitges, M., Cañamero, M., Collado, M., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.149 · Cited by 79
Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer
Lee, K., Lee, Y.-S., Lee, J.-M., Ito, K., Cinghu, S., Kim, J.-H., Jang, J.-W., Yh, L., Goh, Y.-M., Chi, X.-Z., et al. (2010) · Oncogene · doi:10.1038/onc.2010.79 · Cited by 78
Imaging and Oncologic Drug Development
El‐Deiry, W. S., Sigman, C. C., & Kelloff, G. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5623 · Cited by 78
The proto-oncogene KRAS is targeted by miR-200c
Kopp, F. B., Wagner, E., & Roidl, A. (2013) · Oncotarget · doi:10.18632/oncotarget.1427 · Cited by 79
The Role of Gastrin and CCK Receptors in Pancreatic Cancer and other Malignancies
Smith, J. P., Fonkoua, L. A. K., & Moody, T. W. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.14952 · Cited by 80
MAPK pathway activation in the embryonic pituitary results in stem cell compartment expansion, differentiation defects and provides insights into the pathogenesis of papillary craniopharyngioma
Haston, S., Pozzi, S., Carreno, G., Manshaei, S., Panousopoulos, L., González-Meljem, J. M., Apps, J. R., Virasami, A. K., Thavaraj, S., Gutteridge, A., et al. (2017) · Development · doi:10.1242/dev.150490 · Cited by 78
The duality of human oncoproteins: drivers of cancer and congenital disorders
Castel, P., Rauen, K. A., & McCormick, F. P. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0256-z · Cited by 80
Highly Potent, Selective, Biostable, and Cell-Permeable Cyclic d -Peptide for Dual-Targeting Therapy of Lung Cancer
Zhou, Y., Zou, Y., Yang, M., Mei, S., Liu, X., Han, H., Zhang, C.-D., & Niu, M. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c12075 · Cited by 77
Activated KrasG12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin
Rachagani, S., Senapati, S., Chakraborty, S., Ponnusamy, M. P., Sushil Kumar, K., Smith, L., Jain, M., & Batra, S. K. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.31 · Cited by 77
Tissue, cell and stage specificity of (epi)mutations in cancers
Sieber, O. M., Tomlinson, S. R., & Tomlinson, I. P. M. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1674 · Cited by 76
Epitope-Tagged Pkhd1 Tracks the Processing, Secretion, and Localization of Fibrocystin
Bakeberg, J. L., Tammachote, R., Woollard, J. R., Hogan, M. C., Tuan, H.-F., Li, M., van Deursen, J. M., Wu, Y., Huang, B. Q., Torres, V. E., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111173 · Cited by 75
Targeting Ras in myeloid leukemias
Braun, B. S., & Shannon, K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1005 · Cited by 74
Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages
Gonzalez, M. A., Lu, D., Yousefi, M., Kroll, A. V., Lo, C. H., Briseño, C. G., Watson, J. E. V., Novitskiy, S. V., Arias, V., Zhou, H., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221472 · Cited by 75
Ras-Induced Senescence and its Physiological Relevance in Cancer
DiMauro, T., & David, G. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357998 · Cited by 77
Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer
Luengo, A., Abbott, K. L., Davidson, S. M., Hosios, A. M., Faubert, B., Chan, S. H., Freinkman, E., Zacharias, L. G., Mathews, T. P., Clish, C. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13419-4 · Cited by 75
Consequences of RAS and MAPK activation in the ovary: The good, the bad and the ugly
Fan, H., Liu, Z., Mullany, L. K., & Richards, J. S. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.005 · Cited by 73
PI3K isoform dependence of PTEN-deficient tumors can be altered by the genetic context
Schmit, F., Utermark, T., Zhang, S., Wang, Q., Von, T., Roberts, T. M., & Zhao, J. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323004111 · Cited by 75
Somatic p16INK4a loss accelerates melanomagenesis
Monahan, K. B., Rozenberg, G. I., Krishnamurthy, J., Johnson, S. M., Liu, W., Bradford, M. K., Horner, J. W., DePinho, R. A., & Sharpless, N. E. (2010) · Oncogene · doi:10.1038/onc.2010.314 · Cited by 74
Self-citation
The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting
Jonckheere, N., Vasseur, R., & SEUNINGEN, I. V. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.01.002 · Cited by 73
Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation
Tan, X., Lu, T., Li, L., Xu, J., Xie, S., Ji, L., Fu, J., Liu, Q., Shen, S., Liu, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24898-9 · Cited by 72
Photoactivated cationic alkyl-substituted porphyrin binding to g4-RNA in the 5′-UTR of KRAS oncogene represses translation
Faudale, M., Cogoi, S., & Xodo, L. E. (2011) · Chemical Communications · doi:10.1039/c1cc15850c · Cited by 71
Stem cell quiescence acts as a tumour suppressor in squamous tumours
White, A. C., Khuu, J., Dang, C., Hu, J. K., Tran, K. V., Liu, A., Gomez, S., Zhang, Z., Yi, R., Scumpia, P. O., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2889 · Cited by 70
Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405
Probst, B., Lyndsey, M., Isaac, T., Wigley, W. C., & Ferguson, D. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135257 · Cited by 70
Menin determines K-RAS proliferative outputs in endocrine cells
Chamberlain, C. E., Scheel, D. W., McGlynn, K., Kim, H., Miyatsuka, T., Wang, J., Nguyen, V. Q., Zhao, S., Mavropoulos, A., Abraham, A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69004 · Cited by 69
Ras Effector Switching Promotes Divergent Cell Fates in C. elegans Vulval Patterning
Zand, T. P., Reiner, D. J., & Der, C. J. (2011) · Developmental Cell · doi:10.1016/j.devcel.2010.12.004 · Cited by 69
Increased expression of FoxM1 transcription factor in respiratory epithelium inhibits lung sacculation and causes Clara cell hyperplasia
Wang, I., Zhang, Y., Snyder, J. E., Sutherland, M. J., Burhans, M. S., Shannon, J. M., Park, H. J., Whitsett, J. A., & Kalinichenko, V. V. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.08.027 · Cited by 70
Oncogenic K-Ras suppresses IP3-dependent Ca2+ release through remodeling of IP3Rs isoform composition and ER luminal Ca2+ levels in colorectal cancer cell lines
Pierro, C., Cook, S. J., Foets, T., Bootman, M. D., & Roderick, H. L. (2014) · Journal of Cell Science · doi:10.1242/jcs.141408 · Cited by 69
Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment
Piserà, A., Campo, A., & Campo, S. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2018.01.003 · Cited by 70
Oncogenic K‐ras promotes early carcinogenesis in the mouse proximal colon
Calcagno, S. R., Li, S., Colon, M., Kreinest, P. A., Thompson, E. A., Fields, A. P., & Murray, N. R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23383 · Cited by 68
RAS in cellular transformation and senescence
DeNicola, G. M., & Tuveson, D. A. (2009) · European Journal of Cancer · doi:10.1016/s0959-8049(09)70036-x · Cited by 69
Self-citation
Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma
Bourdeaut, F., Hérault, A., Gentien, D., Pierron, G., Ballet, S., Reynaud, S., Paris, R., Schleiermacher, G., Baumann, C., Philippe‐Chomette, P., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.075374 · Cited by 68
Dominant Role of Oncogene Dosage and Absence of Tumor Suppressor Activity in Nras- Driven Hematopoietic Transformation
Xu, J., Haigis, K. M., Firestone, A. J., McNerney, M. E., Li, Q., Davis, E., Chen, S.-C., Nakitandwe, J., Downing, J. R., Jacks, T., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0096 · Cited by 68
Self-citation
Crk proteins transduce FGF signaling to promote lens fiber cell elongation
Collins, T. N., Mao, Y., Li, H., Bouaziz, M., Hong, A., Feng, G., Wang, F., Quilliam, L. A., Chen, L., Park, T., et al. (2018) · eLife · doi:10.7554/elife.32586 · Cited by 70
Neurodevelopmental Aspects of RASopathies
Kim, Y. E., & Baek, S. T. (2019) · Molecules and Cells · doi:10.14348/molcells.2019.0037 · Cited by 68
K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12
Cespedes, M. V., Sancho, F. J., Guerrero, S., Parreno, M., Casanova, I., Pavon, M. A., Marcuello, E., Trias, M., Cascante, M., Capella, G., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl063 · Cited by 67
Colorectal cancer cells with the BRAFV600E mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM
Wickenden, J. A., Jin, H., Johnson, M., Gillings, A. S., Newson, C., Austin, M. J., Chell, S. D., Balmanno, K., Pritchard, C. A., & Cook, S. J. (2008) · Oncogene · doi:10.1038/onc.2008.335 · Cited by 69
Harnessing preclinical mouse models to inform human clinical cancer trials
Gutmann, D. H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28271 · Cited by 69
Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells
Weng, M., Lee, J., Wei, S., Li, Q., Shahamatdar, S., Hsu, D. J., Schetter, A. J., Swatkoski, S., Mannan, P., Garfield, S. H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207673110 · Cited by 69
Isoform-Specific Ras Activation and Oncogene Dependence during MYC- and Wnt-Induced Mammary Tumorigenesis
Jang, J. W.-U., Boxer, R. B., & Chodosh, L. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00404-06 · Cited by 66
The intermediate-activityL597VBRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathwayPreprint
Andreadi, C., Cheung, L.-K. M., Giblett, S. M., PATEL, B., Jin, H., Mercer, K., Kamata, T., Lee, P., Williams, A. G., McMahon, M., et al. (2012) · Genes & Development · doi:10.1101/gad.193458.112 · Cited by 66
Self-citation
Identification of mutant K-Ras-dependent phenotypes using a panel of isogenic cell lines
Vartanian, S., Bentley, C., Brauer, M. J., Li, L., Shirasawa, S., Sasazuki, T., Kim, J.-S., Haverty, P., Stawiski, E., Modrusan, Z., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394130 · Cited by 65
Distinct and Overlapping Sarcoma Subtypes Initiated from Muscle Stem and Progenitor Cells
Blum, J. M., Añó, L., Li, Z., Mater, D. V., Bennett, B. J., Sachdeva, M., Lagutina, I. V., Zhang, M., Mito, J. K., Dodd, L. G., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.020 · Cited by 68
A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways
Mamidipudi, V., & Cartwright, C. A. (2009) · Oncogene · doi:10.1038/onc.2009.293 · Cited by 65
Oncogenic Activating Mutations Are Associated with Local Copy Gain
Modrek, B., Ge, L., Pandita, A., Lin, E., Mohan, S., Yue, P., Guerrero, S., Lin, W. M., Pham, T. Q., Modrusan, Z. D., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0532 · Cited by 65
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
Xu, K., Park, D., Magis, A. T., Zhang, J., Zhou, W., Sica, G., Ramalingam, S. S., Curran, W. J., & Deng, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1012-4 · Cited by 71
A reversible epigenetic memory of inflammatory injury controls lineage plasticity and tumor initiation in the mouse pancreas
Falvo, D. J., Grimont, A., Zumbo, P., Fall, W. B., Yang, J. L., Osterhoudt, A., Pan, G., Rendeiro, A. F., Meng, Y., Wilkinson, J. E., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.11.008 · Cited by 65
Deficient FGF signaling causes optic nerve dysgenesis and ocular coloboma
Cai, Z., Tao, C., Li, H., Ladher, R. K., Gotoh, N., Feng, G., Wang, F., & Zhang, X. (2013) · Development · doi:10.1242/dev.089987 · Cited by 64
Physiological Levels of Pik3caH1047R Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors
Tikoo, A., Roh, V., Montgomery, K. G., Ivetac, I., Waring, P., Pelzer, R., Hare, L., Shackleton, M. J., Humbert, P. O., & Phillips, W. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036924 · Cited by 65
C-Raf Inhibits MAPK Activation and Transformation by B-RafV600E
Karreth, F. A., DeNicola, G. M., Winter, S. P., & Tuveson, D. A. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.017 · Cited by 64
Self-citation
Temporal Requirement of the Protein TyrosinePhosphatase Shp2 in Establishing the Neuronal Fatein Early Retinal Development
Cai, Z., Feng, G., & Zhang, X. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4364-09.2010 · Cited by 63
A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer
Zhao, X., Wang, X., Fang, L., Lan, C., Zheng, X., Wang, Y., Zhang, Y., Han, X., Liu, S., Cheng, K., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.015 · Cited by 65
Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas
Ischenko, I., Petrenko, O., & Hayman, M. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319911111 · Cited by 62
Cholecystokinin and pancreatic cancer: the chicken or the egg?
Smith, J. P., & Solomon, T. E. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00301.2013 · Cited by 61
Mutated K‐rasAsp12 promotes tumourigenesis in ApcMin mice more in the large than the small intestines, with synergistic effects between K‐ras and Wnt pathways
Luo, F., Brooks, D. G., Ye, H., Hamoudi, R., Poulogiannis, G., Patek, C. E., Winton, D. J., & Arends, M. J. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00667.x · Cited by 60
SmgGDS Regulates Cell Proliferation, Migration, and NF-κB Transcriptional Activity in Non-small Cell Lung Carcinoma
Tew, G. W., Lorimer, E., Berg, T. J., Zhi, H., Li, R., & Williams, C. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707526200 · Cited by 60
Tissue-specific p19 Arf regulation dictates the response to oncogenic K-ras
Young, N. P., & Jacks, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004796107 · Cited by 59
Self-citation
Control of colorectal metastasis formation by K-Ras
Smakman, N., Rinkes, I. H. M. B., Voest, E. E., & Kranenburg, O. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.07.001 · Cited by 60
Modelling oncogenic Ras/Raf signalling in the mouse
Karreth, F. A., & Tuveson, D. A. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.12.006 · Cited by 59
Self-citation
Modeling prostate cancer in mice: something old, something new, something premalignant, something metastatic
Irshad, S., & Abate-Shen, C. T. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9409-1 · Cited by 63
Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle
Dreaden, E. C., Kong, Y. W., Morton, S. W., Correa, S., Choi, K. Y., Shopsowitz, K. E., Renggli, K., Drapkin, R., Yaffe, M. B., & Hammond, P. T. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0013 · Cited by 59
Generation of a Transgenic Mouse for Colorectal Cancer Research with Intestinal Cre Expression Limited to the Large Intestine
Xue, Y., Johnson, R., DeSmet, M. L., Snyder, P. W., & Fleet, J. C. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0195 · Cited by 59

Authors: Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., Hingorani, S. R., Zaks, T., King, C., Jacobetz, M. A., Wang, L., Bronson, R. T., Orkin, S. H., DePinho, R. A., & Jacks, T.
Affiliations: Abramson Cancer Center (US)
Howard Hughes Medical Institute (US)
Dana-Farber Cancer Institute (US)
Massachusetts Institute of Technology (US)
The University of Texas MD Anderson Cancer Center (US)
Tufts University (US)
Boston Children's Hospital (US)
Corresponding author: Jacks, Tyler
ORCID: Tuveson, David A
Shaw, Alice T
Willis, Nicholas A
Silver, Daniel P
Jackson, Erica L
Chang, Sandy
Mercer, Kim L
Hock, Hanno
Hingorani, Sunil R
Wang, Lifu
Bronson, Roderick T
Orkin, Stuart H
DePinho, Ronald A
Jacks, Tyler
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2004-04
Volume: 5
Issue: 4
Pages: 375-387
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/s1535-6108(04)00085-6
OpenAlex: W2050389860
Cited by: 798
References: 49
Citations by year: 2026: 15 · 2025: 28 · 2024: 25 · 2023: 22 · 2022: 26 · 2021: 39 · 2020: 26 · 2019: 35 · 2018: 31 · 2017: 33 · 2016: 41 · 2015: 39 · 2014: 48 · 2013: 41 · 2012: 48
FWCI: 14.12
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 3394 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (P30DK050306)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords: KRAS G12D, ras oncogene activation, cell proliferation, fibroblast transformation, embryonic development, lung, gastrointestinal tract, conditional gene expression
MeSH terms: Congenital Abnormalities, Animals, Cell Cycle, Cell Division, Cell Transformation, Neoplastic, Crosses, Genetic, Embryo, Mammalian, Female, Fibroblasts, Male, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Neoplasms, Genes, ras, Stem Cells, Viral Proteins, Tumor Suppressor Protein p53, Cellular Senescence, Gene Expression Regulation, Developmental, Integrases, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks